Introduction
Although it is recognized that patients with liver metastases from malignant tumours may live for considerable periods of time, it is our experience that the onset of deep jaundice is a very poor prognostic sign. This is often regarded as a hopeless clinical situation and an indication for symptomatic treatment only. The development of combination regimens of chemotherapy has allowed more effective treatment of some solid tumours without unacceptable toxic side-effects. At this hospital considerable experience has now been gained in the treatment of solid tumours using one such regimen (Hanham, Newton & Westbury, 1971) . This report concerns seven consecutive patients who presented with jaundice due to metastases from various malignant tumours, and who were treated with quadruple chemotherapy. The technique that has been used in each of these patients is a modification of that of Costanzi & Coltman (1969) Case 4 Mrs C. B. Born 1918. Housewife. This patient was treated in 1968, for an extensive Stage IV carcinoma of the right breast, by radiotherapy and oophorectomy. The following year hepatic metastases became apparent and bilateral adrenalectomy was performed. In May 1971 she became deeply jaundiced with a bilirubin of 24 mg/100 ml. A liver scan confirmed multiple metastases. Combination chemotherapy was initiated and the jaundice decreased (Table 2) . Three course of treatment were given but she died 4 months after developing jaundice.
Case 5 Mrs J. C. Born 1919. Housewife. She first presented in July 1970 with disseminated carcinoma of the breast which was treated initially with parenteral Durabolin with no response. In October 1970 jaundice developed (bilirubin 17 mg/100 ml) with massive hepatomegaly. Quadruple chemotherapy was given and resulted in remission of jaundice. Her clinical condition improved and this was confirmed by improvement of liver function tests (Table 2 ) and serial liver scans. She survived for 12 months on chemotherapy.
Case 6
Mr R. K. Born 1925. Schoolteacher. He underwent a sub-total gastrectomy in 1969 for a prepyloric tumour which histologically was a poorly differentiated adenocarcinoma. He was referred to this hospital in March 1971, deeply jaundiced with a plasma bilirubin of 19 mg/100 ml and gross hepatomegaly. Metastases were confirmed by the liver scan appearance. Three course of quadruple chemotherapy were given with improvement in liver function tests (Table 2 ). Isotope scans showed decrease in liver size and in size of filling defects. He survived for 3 months. At the time of his death his bilirubin was 1 5 mg/100 ml.
Case 7
Mr H. D. Born 1908. Clerk. He presented in February 1970 with multiple subcutaneous nodules and jaundice. Chest X-ray indicated a carcinoma of the bronchus and a biopsy of a cutaneous nodule showed oat cell carcinoma. He was treated with monthly quadruple chemotherapy. His general codition improved initially, although his jaundice gradually deepened and was increasing rapidly until the time of his death (Table 2) in August 1970. Necropsy confirmed multiple metastases from carcinoma of bronchus.
Discussion
It has been shown in the case of breast tumours that patients with extensive liver metastases or jaundice respond very poorly to bilateral adrenalectomy (Schmidt et al., 1971) . Jaffe et al. (1968) showed that the median survival after diagnosis of liver secondaries in various carcinomas was 75 days, and the presence ofjaundice reduced the median survival to 33 days. The influence of various forms of treatment on liver metastases was studied by Mansfield, Kramer & Southard (1970) who investigated the effect of radiotherapy and of single cytotoxic agents on liver metastases by studying the survival of the patients once hepatic metastases had been diagnosed, and by investigating the effect of the agents on the uptake of radioactive isotopes by the liver. They concluded that neither radiotherapy nor chemotherapy affected the length of survival of the patients. Rapoport & Burleson (1970) showed that 5-fluorouracil given intravenously had no effect on survival time, and that those patients with massive hepatomegaly and jaundice had the poorest prognosis. 0  150  84  162  27  114  240  50  10  130  109  168  53  62  190  43  20  108  70  105  52  90  87   37  30  85  35  53  56  52  40  30  40   74  28  41  50  35  43  24  50  62  25  29  45  28  52  17  60  50  25  27  40  25  60  10  70  47  24  25  34  21  70  15  80  44  25  23  32  20  80  19 However, Sullivan (1965) and Ansfield et al. (1971) reported a palliative effect, using intra-arterial infusion of 5-fluorouracil into the hepatic artery, in a variety of metastatic liver tumours. 61%. of their cases showed clinical improvement: many of these cases were jaundiced. The jaundice resolved and there was an improvement in disordered liver function. This method has the disadvantage of long-term intra-arterial cannulation.
The results of treatment of these seven unselected jaundiced patients are encouraging. There were four breast carcinomas, one gastric carcinoma, one alveolar rhabdomyosarcoma and an oat-cell carcinoma of the bronchus. With the exception of the oat-cell carcinoma, the jaudice was relieved. Three cases survived for a year or more: of these three cases, two patients returned to a normal life in the face of what is generally regarded as an extremely unfavourable clinical situation. The longest survivor under treatment was the patient with the alveolar rhabdomyosarcoma who lived 20 months. One patient with a breast tumour is quite well 18 months after quadruple therapy was initiated.
In the six cases which responded to chemotherapy, the level of the plasma alkaline phosphatase, aspartate aminotransferase (SGOT) and alinine aminotransferase (SGPT) fell in parallel with the fall in total bilirubin (Table 3 ). In three cases the uptake of radioactive isotope by the liver returned to a more normal picture.
